期刊文献+

二甲双胍对急性早幼粒细胞白血病细胞系NB4的作用及机制探讨 被引量:6

Effect of Metformin on Acute Promyelocytic Leukemia Cell Line NB4 and its Mechanism
下载PDF
导出
摘要 本研究旨在探讨二甲双胍对急性早幼粒细胞白血病细胞系NB4细胞生物学特性的影响及可能的作用机制。采用不同浓度的二甲双胍处理NB4细胞,MTT法检测细胞增殖情况,流式细胞术检测细胞凋亡情况,通过细胞黏附实验分析药物对细胞黏附能力的影响。采用细胞外信号调节激酶(ERK)磷酸化抑制剂U0126预处理NB4细胞,Western blot观察ERK磷酸化水平的变化,同时检测细胞凋亡和黏附能力的改变。结果表明,二甲双胍能抑制NB4细胞增殖,诱导细胞凋亡,增强细胞的黏附能力。5μmol/L U0126预处理有效抑制NB4细胞中ERK的磷酸化,降低5 mmol/L二甲双胍诱导的细胞凋亡并减弱细胞的黏附能力。结论:二甲双胍对NB4细胞有抑制增殖、促进凋亡和黏附的作用,MEK/ERK信号通路可能是二甲双胍在NB4细胞中的分子作用机制之一。 The purpose of this study was to investigate the effect and molecular mechanism of metformin (Met) on biological characteristics of acute promyelocytic leukemia (APL) cell line NB4. NB4 cells were treated with various concentrations of Met for different time, MTr method was used to detect cell proliferation, the alteration of cell apoptosis was analyzed by flow cytometry, and the change of cell adhesion ability was examined by cell adhesion assay. NB4 cells were pretreated with U0126, a specific inhibitor for extracellular signal-regulated kinase (ERK) phosphorylation, ERK phosphorylation was assessed by Western blot analysis, apoptosis and cell adhesion ability were evaluated by flow cytometry and cell adhesion test respectively. The results showed that Met could inhibit the cell proliferation, induce the cell apoptosis and increase the ability of cell adhesion. The pretreatment of NB4 cells with 5 μmol/L U0126 could effectively inhibit the phosphorylation of ERK, and reduce cell apoptosis and adhesion induced by 5 mmol/L Met. It is concluded that Met can inhibit the proliferation and promote the apoptosis and adhesion of NB4 cells. MEK/ERK signaling pathway may be one of the molecular mechanisms of metformin on NB4 cells.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第6期1322-1326,共5页 Journal of Experimental Hematology
基金 国家自然基金(编号30971290) 天津市应用基础研究计划重点项目(编号10JCZDJC19600)
关键词 二甲双胍 急性早幼粒细胞白血病 NB4细胞系 MEK/ERK信号通路 mefformin acute promyelocytic leukemia NB4 cell line MEK/ERK signaling pathway
  • 相关文献

参考文献12

  • 1Hundal RS, Krssak M, Dufour S, et al. Mechanism by whichmetformin reduces glucose productio in type 2 diabetes. Diabetes, 2000; 49(12) : 2063 -2069.
  • 2Holland W, Morrison T, Chang Y, et al. Metformin (Gluco- phage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase. Biochem Pharmacol, 2004; 67 (11) : 2081 - 2091.
  • 3Bowker SL, Majumdar SR, Veugelers P, et al. Increased cancer- related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care, 2006; 29 (2) : 254 -258.
  • 4Libby G, Donnelly LA, Donnan PT, et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care, 2009; 32(9) : 1620 - 1625.
  • 5Huai L, Wang CC, Zhang CP, et al. Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Biochem Biophys Res Commun, 2012 ; 422(3) :398 -404.
  • 6Scarpello JH. Improving survival with metformin: the evidence base today. Diabetes Metab, 2003; 29(4 Pt 2) : 6S36-6S43.
  • 7Ben Sahra I, Laurent K, Loubat A, et al. The antidiabetic drugmetformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin DI level. Oncogene, 2008 ; 27 ( 25 ) : 3576 - 3586.
  • 8Zaldkhani M, Dowling R, Fantus IG, et al. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res, 2006 ; 66(21 ) : 10269 - 10273.
  • 9Iliopoulos D, Hirsch HA, Struhl K. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xeno- grafts involving multiple cancer cell types. Cancer Res, 2011 ; 71 (9) : 3196 -3201.
  • 10Rattan R, Graham RP, Maguire JL, et al. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia, 2011 ; 13(5) : 483 -491.

同被引文献31

  • 1Ben SI,Laurent K,Loubat A,et al.The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.Oncogene,2008;27(25):3576-3586.
  • 2Dowling RJ,Zakikhani M,Fantus I G,et al.Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.Cancer Res,2007;67(22):10804-10812.
  • 3Cantrell LA,Zhou CX,Mendivil A,et al.Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy.Gynecol Oncol,2010;116(1):92-8.
  • 4Kato K,Gong J,Iwama H,et al.The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.Mol Cancer Ther,2012;11(3):549-560.
  • 5Miyoshi H,Kato K,Iwama H,et al.Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.Int J Oncol,2014;45(1):322-332.
  • 6Zhang T,Guo P,Zhang Y,et al.The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo.Int J Mol Sci,2013;14(12):24603-24618.
  • 7Berstein LM,Boyarkina MP,Teslenko SY.Familial diabetes is associated with reduced risk of cancer in diabetic patients:a possible role for metformin.Med Oncol,2012;29(2):1308-1313.
  • 8Viollet B,Guigas B,Sanz GN,et al.Cellular and molecular mechanisms of metformin:an overview.Clin Sci(Lond),2012;122(6):253-270.
  • 9Kalender A,Selvaraj A,Kim SY,et al.Metformin,independent of AMPK,inhibits m TORC1 in a rag GTPase-dependent manner.Cell Metab,2010;11(5):390-401.
  • 10Ben SI,Regazzetti C,Robert G,et al.Metformin,independent of AMPK,induces m TOR inhibition and cell-cycle arrest through REDD1.Cancer Res,2011;71(13):4366-4372.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部